AI-backed imaging and care coordination company Viz.ai received FDA 510(k) clearance for an algorithm that could help determine the severity of a pulmonary embolism. The startup received the agency's ...
– Sheba Medical Center, a globally recognized healthcare leader, announced the publication of a groundbreaking study demonstrating the effectiveness of an AI algorithm in predicting pulmonary embolism ...
The past couple of days have seen a handful of artificial intelligence algorithms for radiology imaging analysis receive 510(k) clearances from the FDA. Two of these, from Quantib and Ezra, are ...
Sheba Medical Center in Ramat Gan, central Israel, has developed an algorithm that accurately predicts the likelihood of a patient suffering a PE when admitted to the hospital. IBRANDIFY ON FREEPIK.
An artificial intelligence algorithm developed at Sheba Medical Center in Israel can identify patients at high risk of pulmonary embolism as soon as they walk through the hospital doors, a study ...
About The Study: In patients with cancer and suspected pulmonary embolism, a diagnostic strategy using the YEARS diagnostic algorithm was as safe as using computed tomographic pulmonary angiography ...
– Viz.ai, a provider of AI-powered disease detection and intelligent care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an automated RV/LV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results